Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Liver Cirrhosis, Experimental D008106 36 associated lipids
Fever D005334 35 associated lipids
Glomerulonephritis D005921 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Epilepsy D004827 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Burns D002056 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Bekker AY et al. Dose-response relationships between platelet activating factor and permeability--surface area product of FITC-dextran 150 in the hamster cheek pouch. 1988 Microcirc Endothelium Lymphatics pmid:2475751
Vivier E et al. Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression. 1988 Eur. J. Immunol. pmid:2895712
Hoffman DR et al. Synthesis of platelet activating factor by cholinephosphotransferase in developing fetal rabbit lung. 1988 Lipids pmid:2897059
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Junier MP et al. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. 1988 Endocrinology pmid:2898362
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Russell JA et al. Changes in the levels of bioactive components of cotton bracts accompanying senescence. 1988 Lung pmid:3132575
Martins MA et al. Intravenous injections of PAF-acether induce platelet aggregation in rats. 1988 Eur. J. Pharmacol. pmid:3135199
Peers SH Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats. 1988 Eur. J. Pharmacol. pmid:3136026
Mangold HK Synthesis of biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3136454
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Winkler JD et al. Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells. 1988 J. Pharmacol. Exp. Ther. pmid:2839662
Croft KD et al. Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes. 1988 Clin. Exp. Pharmacol. Physiol. pmid:2856061
Berti F et al. New pharmacological data on the bronchospasmolytic activity of bamifylline. 1988 Arzneimittelforschung pmid:3365275
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Calignano A et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. 1988 J Pharmacol Methods pmid:3367652
Rydzewska G and Gabryelewicz A [Platelet activating factor (PAF) and its inhibitors]. 1988 Pol. Arch. Med. Wewn. pmid:2482481
Jouquey S et al. Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. 1988 Agents Actions pmid:2459935
Spinks NR and O'Neill C Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. 1988 J. Reprod. Fertil. pmid:2460623
Dorsch W et al. Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. 1988 Biochem. Pharmacol. pmid:2462422
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Bratton DL et al. Effects of platelet activating factor on calcium-lipid interactions and lateral phase separations in phospholipid vesicles. 1988 Biochim. Biophys. Acta pmid:3401478
Evans TW et al. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. 1988 Br. J. Pharmacol. pmid:3401633
Lagente V et al. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3401641
Groscurth P et al. Effects of platelet activating factor (PAF) on human citrated whole blood. 1988 Eur. J. Haematol. pmid:3402585
Rylander R et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). 1988 Int. Arch. Allergy Appl. Immunol. pmid:3403044
O'Neill C et al. Embryo-derived platelet-activating factor. Its diagnostic and therapeutic future. 1988 Ann. N. Y. Acad. Sci. pmid:3195924
Ninio E et al. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance. 1988 Biochim. Biophys. Acta pmid:3196734
Kumar R et al. Production and effects of platelet-activating factor in the rat brain. 1988 Biochim. Biophys. Acta pmid:3196741
Bette-Bobillo P and Bienvenue A Platelet-activating-factor-induced serum-albumin release from rabbit platelets in the absence of calcium. 1988 Eur. J. Biochem. pmid:3197724
Cueva JP and Hsueh W Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. 1988 Gut pmid:3197995
Bass DA et al. Selective priming of rate and duration of the respiratory burst of neutrophils by 1,2-diacyl and 1-O-alkyl-2-acyl diglycerides. Possible relation to effects on protein kinase C. 1988 J. Biol. Chem. pmid:3198643
Lewis MS et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. 1988 J. Clin. Invest. pmid:3198764
Pirotzky E and Braquet P [The role of the platelet-activating factor (PAF-acether) in renal pathology]. 1988 Presse Med pmid:2966954
Keery RJ and Lumley P AH6809, a prostaglandin DP-receptor blocking drug on human platelets. 1988 Br. J. Pharmacol. pmid:2460179
Willuweit B and Aktories K Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:2969081
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Tkhostov EB et al. [Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:2969736
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Wallace JL Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. 1988 Can. J. Physiol. Pharmacol. pmid:3167675
Stenson WF Platelet-activating factor and inflammatory bowel disease. 1988 Gastroenterology pmid:3169505
Valone FH et al. Enhanced human monocyte cytotoxicity by platelet-activating factor. 1988 Immunology pmid:3169845
Popovich KJ et al. Role of platelets in contraction of canine tracheal muscle elicited by PAF in vitro. 1988 J. Appl. Physiol. pmid:3170437
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. 1988 J. Pharmacol. Exp. Ther. pmid:3171975
Weisman SM et al. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. 1988 Biochem. Pharmacol. pmid:2840083
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Lagente V et al. Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen. 1988 Int. Arch. Allergy Appl. Immunol. pmid:3338855
Imai T et al. Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021. 1988 J. Lab. Clin. Med. pmid:3339274
Wichrowski B et al. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres. 1988 J. Med. Chem. pmid:3339611
Tilley JW et al. Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists. 1988 J. Med. Chem. pmid:3339617
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Kelefiotis D et al. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. 1988 Life Sci. pmid:3339951
Barnes PJ et al. Platelet-activating factor as a mediator of allergic disease. 1988 J. Allergy Clin. Immunol. pmid:3286723
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Chung KF et al. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. 1988 J. Allergy Clin. Immunol. pmid:3288683
Page CP and Robertson DN The role of PAF in altered airway responsiveness. 1988 Prog. Clin. Biol. Res. pmid:3289016
Arnout J et al. Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. 1988 Br J Clin Pharmacol pmid:3289599
O'Donnell SR and Barnett CJ pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. 1988 Br. J. Pharmacol. pmid:3293683
Giovannini L et al. N-acetyl-beta-glucosaminidase (NAG) and alpha-glycosidase released by PAF in isolated perfused rat kidney. 1988 Int J Tissue React pmid:3294206
Nakayama R et al. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity. 1988 Biochem. Biophys. Res. Commun. pmid:3355555
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
McGowan HM et al. Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. 1988 Clin. Sci. pmid:3356112
Abraham WM and Wanner A Inflammatory mediators of asthma. 1988 Pediatr. Pulmonol. pmid:2455882
Huang SJ et al. Platelet-activating factor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate stimulates the production of reactive oxygen intermediates in macrophages. 1988 Biochem. J. pmid:2833227
Brass LF et al. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. 1988 J. Biol. Chem. pmid:2833506
Blank ML et al. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. 1988 J. Biol. Chem. pmid:2833508
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Worthen GS et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. 1988 J. Immunol. pmid:2834441
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Errasfa M et al. Inhibition of phospholipase A2 activity of guinea-pig alveolar macrophages by lipocortin-like proteins purified from mice lung. 1988 Biochem. Biophys. Res. Commun. pmid:2968795
Hammerschmidt DE et al. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. 1988 J. Lab. Clin. Med. pmid:2840477
Hwang SB et al. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. 1988 J. Pharmacol. Exp. Ther. pmid:2841449
Parnham MJ PAF receptors. 1988 Prog Biochem Pharmacol pmid:2841664
Morley J et al. Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. 1988 Agents Actions Suppl. pmid:3262989
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Subissi A and Criscuoli M Effects of LG 30435 on different platelet activating factor-induced responses. 1988 Agents Actions Suppl. pmid:3262990
Tahraoui L et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. 1988 Mol. Pharmacol. pmid:2842653
Heuer H and Casals-Stenzel J Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. 1988 Agents Actions Suppl. pmid:3262991
Ontell SJ et al. Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. 1988 Gastroenterology pmid:3263295
Breviario F et al. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. 1988 J. Immunol. pmid:3263425
Page CP The role of platelet-activating factor in asthma. 1988 J. Allergy Clin. Immunol. pmid:3276759
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Storch J et al. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. 1988 J. Leukoc. Biol. pmid:2846728
Bussolino F et al. Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. 1988 J. Neurochem. pmid:2846783
Birkle DL et al. Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. 1988 J. Neurochem. pmid:2846788
Altman R et al. Why single daily dose of aspirin may not prevent platelet aggregation. 1988 Thromb. Res. pmid:3140408
Rouis M et al. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. 1988 Biochem. Biophys. Res. Commun. pmid:2847729
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Ryan US et al. Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. 1988 J. Appl. Physiol. pmid:3209566
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345
Schwertschlag US et al. Nonimmunological alterations of glomerular filtration by s-PAF in the rat kidney. 1988 Kidney Int. pmid:3210538
Rubin RM and Rosenbaum JT A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. 1988 Biochem. Biophys. Res. Commun. pmid:3260779
Fisher RA et al. AGEPC: a potent calcium-dependent chemical mediator in the liver. 1988 Adv. Exp. Med. Biol. pmid:3213685
Mickelson JK et al. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. 1988 J. Mol. Cell. Cardiol. pmid:3216407
Bussolino F [Production of PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in the chick retina during embryogenesis]. 1988 Ann. Ist. Super. Sanita pmid:3218801
Dillon PK et al. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships. 1988 Inflammation pmid:3220518